21 results on '"Buesa, Carlos"'
Search Results
2. Iadademstat Combination with Azacitidine Is a Safe and Effective Treatment in First Line Acute Myeloid Leukemia. Final Results of the Alice Trial
Catalog
Books, media, physical & digital resources
3. Iadademstat Combination with Azacitidine Is a Safe and Effective Treatment in First Line Acute Myeloid Leukemia. Final Results of the Alice Trial
4. First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia.
5. Iadademstat in combination with azacitidine in patients with newly diagnosed acute myeloid leukaemia (ALICE): an open-label, phase 2a dose-finding study
6. P2‐005: SAFETY EVALUATION OF VAFIDEMSTAT ON MILD TO MODERATE ALZHEIMER'S SUBJECTS.
7. Iadademstat in Combination with Azacitidine Generates Robust and Long Lasting Responses in AML Patients (ALICE Trial)
8. Iadademstat in Combination with Azacitidine Generates Robust and Long Lasting Responses in AML Patients (ALICE Trial)
9. Vafidemstat in mild to moderate Alzheimer's disease: The ETHERAL study European cohort interim analysis: Update on pharmacologic and nonpharmacologic interventions.
10. Vafidemstat in mild to moderate Alzheimer's disease: The ETHERAL study European cohort interim analysis: Update on pharmacologic and nonpharmacologic interventions.
11. Primary Structure of Scombrine α: Two Different Species with an Identical Protamine
12. A nonsense mutation in the 3-hydroxy-3-methylglutaryl-CoA lyase gene produces exon skipping in two patients of different origin with 3-hydroxy-3-methylglutaryl-CoA lyase deficiency
13. Coordinated expression and activity of 3-hydroxy-3-methylglutaryl coenzyme a synthase and reductase in the fat body of Blattella germanica(L.) during vitellogenesis
14. The Primary Structure of a Chondrichthyan Protamine: A New Apparent Contradiction in Protamine Evolution
15. Robust Efficacy Signals in Elderly AML Patients Treated with Iadademstat in Combination with Azacitidine (ALICE Phase IIa Trial)
16. Robust Efficacy Signals in Elderly AML Patients Treated with Iadademstat in Combination with Azacitidine (ALICE Phase IIa Trial)
17. Iadademstat Shows Efficacy in Elderly AML Patients in Combination with Azacitidine. Alice Trial
18. Iadademstat Shows Efficacy in Elderly AML Patients in Combination with Azacitidine. Alice Trial
19. ORY-2001: AN EPIGENETIC DRUG FOR THE TREATMENT OF COGNITION DEFECTS IN ALZHEIMER’S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS.
20. The dual lsd1/maob inhibitor ory2001 prevents the development of the memory deficit in samp8 mice through induction of neuronal plasticity and reduction of neuroinflammation.
21. DNA Chip Technology in Brain Banks: Confronting a Degrading World
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.